Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm.

Tchou J, Conejo-Garcia J.

Adv Pharmacol. 2012;65:45-61. doi: 10.1016/B978-0-12-397927-8.00003-8. Review.

PMID:
22959023
2.

Tumor stroma as targets for cancer therapy.

Zhang J, Liu J.

Pharmacol Ther. 2013 Feb;137(2):200-15. doi: 10.1016/j.pharmthera.2012.10.003. Epub 2012 Oct 12. Review.

3.

Stromal cells in tumor microenvironment and breast cancer.

Mao Y, Keller ET, Garfield DH, Shen K, Wang J.

Cancer Metastasis Rev. 2013 Jun;32(1-2):303-15. doi: 10.1007/s10555-012-9415-3. Review.

4.

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast.

Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, Simon W, Mürdter TE, Aulitzky WE.

BMC Cancer. 2008 Dec 11;8:364. doi: 10.1186/1471-2407-8-364.

5.

Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression.

Luo H, Tu G, Liu Z, Liu M.

Cancer Lett. 2015 Jun 1;361(2):155-63. doi: 10.1016/j.canlet.2015.02.018. Epub 2015 Feb 17. Review.

PMID:
25700776
6.

The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.

Bremnes RM, Dønnem T, Al-Saad S, Al-Shibli K, Andersen S, Sirera R, Camps C, Marinez I, Busund LT.

J Thorac Oncol. 2011 Jan;6(1):209-17. doi: 10.1097/JTO.0b013e3181f8a1bd. Review.

7.

Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy.

Ren Y, Zhou X, Liu X, Jia HH, Zhao XH, Wang QX, Han L, Song X, Zhu ZY, Sun T, Jiao HX, Tian WP, Yang YQ, Zhao XL, Zhang L, Mei M, Kang CS.

Cancer Lett. 2016 Apr 28;374(1):96-106. doi: 10.1016/j.canlet.2016.02.003. Epub 2016 Feb 9.

PMID:
26872723
8.

Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.

Wang RF, Zhang LH, Shan LH, Sun WG, Chai CC, Wu HM, Ibla JC, Wang LF, Liu JR.

Exp Mol Pathol. 2013 Dec;95(3):350-56.

PMID:
24422232
9.

Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Li X, Ma Q, Xu Q, Duan W, Lei J, Wu E.

Curr Pharm Des. 2012;18(17):2404-15. Review.

10.

Activation of fibroblasts in cancer stroma.

Räsänen K, Vaheri A.

Exp Cell Res. 2010 Oct 15;316(17):2713-22. doi: 10.1016/j.yexcr.2010.04.032. Epub 2010 May 6. Review.

PMID:
20451516
11.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
12.

Stromal induction of breast cancer: inflammation and invasion.

Radisky ES, Radisky DC.

Rev Endocr Metab Disord. 2007 Sep;8(3):279-87. Review.

PMID:
17447144
13.

Cancer-associated fibroblasts in digestive tumors.

Huang L, Xu AM, Liu S, Liu W, Li TJ.

World J Gastroenterol. 2014 Dec 21;20(47):17804-18. doi: 10.3748/wjg.v20.i47.17804. Review.

14.

Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.

El-Nikhely N, Larzabal L, Seeger W, Calvo A, Savai R.

Expert Opin Investig Drugs. 2012 Aug;21(8):1107-22. doi: 10.1517/13543784.2012.693478. Epub 2012 Jun 6. Review.

PMID:
22667993
15.

Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.

Erez N, Glanz S, Raz Y, Avivi C, Barshack I.

Biochem Biophys Res Commun. 2013 Aug 2;437(3):397-402. doi: 10.1016/j.bbrc.2013.06.089. Epub 2013 Jul 2.

PMID:
23831470
16.

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.

Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD.

BMC Cancer. 2011 Jun 13;11:245. doi: 10.1186/1471-2407-11-245.

17.

Tumor-stroma crosstalk: targeting stroma in breast cancer.

Criscitiello C, Esposito A, Curigliano G.

Curr Opin Oncol. 2014 Nov;26(6):551-5. doi: 10.1097/CCO.0000000000000122. Review.

PMID:
25279962
18.

The tumor microenvironment: a target for combination therapy of breast cancer.

Reisfeld RA.

Crit Rev Oncog. 2013;18(1-2):115-33. Review.

PMID:
23237555
19.

Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

Micke P, Ostman A.

Lung Cancer. 2004 Aug;45 Suppl 2:S163-75. Review.

PMID:
15552797
20.

Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.

Brennen WN, Isaacs JT, Denmeade SR.

Mol Cancer Ther. 2012 Feb;11(2):257-66. doi: 10.1158/1535-7163.MCT-11-0340. Review.

Supplemental Content

Support Center